Abstract
This case illustrates a 31-year-old female who presented with thyrotoxicosis and mild thyroid eye disease. Questions relating to this common thyroid condition are addressed in a systematic fashion, including a summary of the clinical signs and symptoms, the appropriate biochemical and radiological investigations, management and follow-up. This case nicely demonstrates the spectrum and heterogeneity of hyperthyroidism in terms of disease severity and response to medication. Although most patients respond well to anti-thyroid drugs, this patient was refractory to this treatment, as shown by her growing goitre and worsening biochemical results despite high dosages of carbimazole. Her condition was eventually treated with total thyroidectomy. The management options for more aggressive Graves’ disease are discussed along with other questions about the case study.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mier A, Brophy C, Wass JA, Besser GM, Green M. Reversible respiratory muscle weakness in hyperthyroidism. Am Rev Respir Dis. 1989;139(2):529–33.
Kendall-Taylor P, Perros P. Clinical presentation of thyroid associated orbitopathy. Thyroid. 1998;8(5):427–8.
Bartalena L, Marcocci C, Tanda ML, Manetti L, Dell’Unto E, Bartolomei MP, et al. Cigarette smoking and treatment outcome in Graves’ ophthalmopathy. Ann Intern Med. 1998;129:633–5.
Vestergaard P. Smoking and thyroid disorders – a meta-analysis. Eur J Endocrinol. 2002;146(2):153–61.
Strieder TG, Tijssen JG, Wenzel BE, Endert E, Wiersinga WM. Prediction of progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score. Arch Intern Med. 2008;168(15):1657–63.
Weetman AP, Tomlinson K, Amos N, Lazarus JH, Hall R, McGregor AM. Proteinuria in autoimmune thyroid disease. Acta Endocrinol (Copenh). 1985;109(3):341–7.
Androuny A, Sandler RM, Carmel R. Variable presentation of thrombocytopenia in Graves’ disease. Arch Intern Med. 1982;142(8):1460–4.
Mitchell AL, Pearce SH. How should we treat patients with low serum thyrotropin concentrations? Clin Endocrinol. 2010;72(3):292–6.
Yoshimura Noh J, Momotani N, Fukada S, Ito K, Miyauchi A, Amino N. Ratio of serum free triiodothyronine to free thyroxine in Graves’ hyperthyroidism and thyrotoxicosis caused by painless thyroiditis. Endocr J. 2005;52(5):537–42.
Eckstein AK, Plicht M, Lax H, Neuhauser M, Mann K, Lederbogen S, et al. Thyrotropin receptor autoantibodies are independent risk factors for Graves’ ophthalmopathy and help to predict severity and outcome of the disease. J Cin Endocrinol Metab. 2006;91(9):3464–70.
Grebe SK, Feel CM, Ford HC, Fagerstrom JN, Cordwell DP, Delahunt JW, et al. A randomized trial of short-term treatment of Graves’ disease with high-dose carbimazole plus thyroxine versus low-dose carbimazole. Clin Endocrinol (Oxf). 1998;48(5):585–92.
Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell’Untol E, et al. Relation between therapy for hyperthyroidism and the course of Graves’ ophthalmopathy. N Engl J Med. 1998;338(2):73–8.
Lai A, Sassi L, Compri E, Marino F, Sivelli P, Piantanida E, et al. Lower dose prednisolone prevents radioiodine-associated exacerbation of initially mild or absent graves’ orbitopathy: a retrospective cohort study. J Clin Endocrinol Metab. 2010;95(3):1333–7.
Suggested Reading
Braverman LE, Cooper D. Werner & Ingbar’s the thyroid: a fundamental and clinical text. 10th ed. Philadelphia: Lippincott, Williams & Wilkins; 2012.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag London
About this chapter
Cite this chapter
Gan, E.H., Pearce, S.H.S. (2015). Difficult-to-Treat Hyperthyroidism. In: Ajjan, R., Orme, S. (eds) Endocrinology and Diabetes. Springer, London. https://doi.org/10.1007/978-1-4471-2789-5_1
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2789-5_1
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2788-8
Online ISBN: 978-1-4471-2789-5
eBook Packages: MedicineMedicine (R0)